Atopic dermatitis as an actual problem of modern allergology

Polski Merkuriusz Lekarski

Volumn 14, Issue 84, 2003, Pages 602-604

  Fedenko, Elena ^a  

^a INSTITUTE OF IMMUNOLOGY   (Russian Federation)

Author keywords

Atopic dermatitis; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; CORTICOSTEROID; EMOLLIENT AGENT; GLUCOCORTICOID; SEDATIVE AGENT;

AGE; ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; CLINICAL IMMUNOLOGY; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; PATHOGENESIS; SEDATION; SIDE EFFECT; TOPICAL TREATMENT;

ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; HUMANS;

EID: 0038444387     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Atopic dermatitis. Russian Position Paper. Moscow. 2002, 192.
2. Atherton D.J.: A double-blind controlled trial of hyposensitisation to Dermatophagoides pteronissinus in children with atopic exema. Clin. Exp. Allergy, 1992, 22, 440-446.
3. Barnes P.J.: New directions in allergic diseases: mechanism-based antiinflammatory therapies. J. Allergy Clin. Immunol. 2000, 106, 5-16.
4. Berth-Jones J., Graham-Brown R.A.C.: Treatment of itching in atopic eczema. Br. Med. J., 1989, 298, 491-492.
5. Chait I., Allkins V.: Remission of life-long atopic dermatitis after hyposensitisation to house dust mite. Practitioner. 1985, 229, 609-612.
6. Fuenmayer M., Di Prisco M.C., Champion R.H.: Specific hyposensitization in atopic dermatitis. Br. J. Dermatol., 1979, 101, 697-700.
7. Glover M.T., Atherton D.J.: A double-blind controlled trial of hyposensitization to Dermatophagoides pteronissinus in children with atopic exema. Clin. Exp. Allergy. 1992, 22, 440-446.
8. Hanifin J.M.: Breaking the cycle. How I manage difficult cases of atopic dermatitis. Fitzpatrick's J. Dermatol., 1994, 1, 13-26.
9. Hens B.M. i wsp.: Differential effects of new-generation H1-receptor antagonists in pruritic dermatoses. Allergy. 1998, 53, 180-183.
10. Johansson S.G.O. i wsp.: Position paper. A revised nomenclature for allergy. Allergy. 2001, 56, 813-824.
11. Klein P.A., Clark R.A.: An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch. Dermatol., 1999, 135, 1522-1525.
12. Kligman A.M., Frosch P.J.: Steroid addiction. J. Int. Dermatol., 1979, 18, 23-31.
13. McLean C., Lobo R., Brazier D.: Cataracts, glaukoma, femoral avascular necrosis caused by topical corticosteroid oinment. Lancet. 1995, 345, 3330.
14. Oranje A.P., Wolkerstorfer A.: Advances in the treatment of atopic dermatitis with special regard to children. Am. Fam. Phys., 1999, 60, 1198-1205.
15. Schultz Larsen F.: The epidemiology of atopic dermatitis. In: Epidemiology of Clinical Allergy. Basel, Karger., 1993, 31, 9-28.
16. Sidbury R., Hanifin J.M.: Systemic therapy of atopic dermatitis. Clin. Exp. Dermatol., 2000, 25, 559-566.
17. Werfel T., Kapp A.: The role of environmental factors in the provocation of atopic dermatitis. Allergy Clin. Immunol., 1999, 11, 49-54.
18. Williams H.C., Strachan D.P., May R.J.: Childhood eczema: disease of the advantage. Br. Med. J., 1994, 308, 1132-1135.
19. WHO Position Paper Allergen Immunotherapy: therapeutic vaccines for allergic diseases. Allergy, 1998, 53, suppl., 42.
20. Yawalkar N. i wsp.: Down regulation oh IL-12 by topical corticosteroids in chronic atopic dermatitis. J. Allergy Clin. Immunol., 2000, 106, 5, 991-947.